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Abstract
The pluripotency factor Lin28 blocks the expression of let-7 microRNAs (miRNAs) in
undifferentiated cells during development and functions as an oncogene in a subset of cancers1.
Lin28 binds to let-7 precursor RNAs and recruits 3′ terminal uridylyl transferases (TUTases) to
selectively inhibit let-7 biogenesis2–4. Uridylated pre-let-7 is refractory to processing by Dicer and
is rapidly degraded by an unknown ribonuclease5. Here we identify Dis3l2 as the 3′-5′
exonuclease responsible for the decay of uridylated pre-let-7. Biochemical reconstitution assays
reveal that 3′ oligouridylation stimulates Dis3l2 activity in vitro, and knockdown of Dis3l2 in
mouse embryonic stem cells leads to the stabilization of pre-let-7. Our study establishes 3′
oligouridylation as an RNA decay signal for Dis3l2 and identifies the first physiological RNA
substrate of this novel exonuclease that is mutated in the Perlman syndrome of fetal overgrowth
and predisposition to Wilms’ tumor6.
Keywords
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Posttranscriptional gene regulation by miRNAs impacts many developmental and
physiological processes. Functioning by base-pairing with target messenger RNAs of
complementary sequence these ~22 nucleotides RNAs recruit the miRNA-induced silencing
complex for translational repression and mRNA decay. Of particular relevance is the ancient
let-7 family of miRNAs that are essential for normal development of C. elegans. Loss of
their tumor suppressor function impacts various human cancers7. Let-7 expression is
dynamically regulated during development by the paralogous RNA-binding proteins Lin28A
and Lin28B5,8–10. Lin28 was identified as a regulator of developmental timing in worms,
and more recently has been linked with controlling developmental timing and growth of
mammals as well as maintaining glucose homeostasis1,11–13. Lin28 is a pluripotency factor
in stem cells where its expression helps maintain an undifferentiated and proliferative state
by blocking let-7 expression14,15. The Lin28-let-7 pathway is normally silenced in adult
somatic cells yet expression of Lin28A or Lin28B is associated with a wide variety of
2Corresponding author: Richard I. Gregory, Phone: (617) 919-2273, Fax: (617) 730-0748, rgregory@enders.tch.harvard.edu.
AUTHOR CONTRIBUTIONS
H.C. designed and performed most of the experiments in Figures 1 and 2 and all of the experiments in Figure 4. H.C. R.T. and J.E.T
designed and performed experiments in Figures 1–4 as well as the Supplementary Figures. R.I.G., and H.C., wrote the paper with
input from R.T. and J.E.T. The authors 11 declare no competing financial interests.
NIH Public Access
Author Manuscript
Nature. Author manuscript; available in PMC 2013 November 09.
Published in final edited form as:
Nature. 2013 May 9; 497(7448): 244–248. doi:10.1038/nature12119.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
thuman cancers16,17. Inhibition of this oncogenic pathway blocks the tumorigenicity of
cancer cells16.
Recent work has provided insight into the mechanisms underlying the Lin28-mediated
selective regulation of let-718. Lin28A functions in the cell cytoplasm where it recruits 3′
terminal uridylyl transferases (TUTase), Zcchc11 (TUT4) and Zcchc6 (TUT7), that adds an
oligouridine tail to pre-let-7 to inhibit Dicer processing and is thought to serve as a signal for
the rapid decay of the uridylated RNA by an unknown nuclease2–5,16. We sought to identify
the downstream nuclease(s) and utilized a biochemical approach to isolate factors that
specifically associate with uridylated pre-let-7 (Figure 1a, Supplementary Figure S1, and
Supplementary Table 1). This analysis identified that Lin28A and Zcchc11 were associated
with both RNAs whereas Dis3l2 [DIS3 mitotic control homolog (S. cerevisiae)-like 2], a
3′-5′ exonuclease, was specifically detected in the pre-let-7+14U purification (Figure 1b)6.
These mass spectrometry data were confirmed by Western blot (Figure 1c). Co-
immunoprecipitation (co-IP) assays using a mouse ESC line expressing Dox-inducible Flag-
Lin28 transgene revealed that Zcchc11, Zcchc6, as well as Dis3l2 are detectable by Western
blot in the Flag-Lin28A affinity eluate (Figure 1d). Additional co-IPs with Flag-TRBP, a
cytoplasmic miRNA-binding protein, and Flag-Trim71, a cytoplasmic RNA binding protein
highly expressed in ESCs, confirmed the specificity of the Dis3l2 association with Lin28
(Figure 1e)15,19. To address whether this association is mediated through RNA we
performed additional co-IPs using either wild-type Lin28 or a mutant Lin28 (W46A) protein
that exhibits compromised RNA binding activity towards pre-let-718. We found less Dis3l2
associated with mutant Lin28, and that this association is strongly reduced upon RNase A
treatment (Figure 1f). Overall these results indicate that Lin28A associates with Dis3l2 in a
RNA-dependent manner and implicate Dis3l2 as a possible nuclease in the Lin28-let-7
pathway.
We next cloned and sequenced Dis3l2 cDNA from ESCs. Dis3l2.2 was confirmed as the
major transcript variant expressed in V6.5 ESC that encodes a 870 amino acid protein
(Figure 1b and Supplementary Figure 2). Since pre-let-7 degradation occurs in the cell
cytoplasm we next examined the subcellular localization of Dis3I2 in ESCs (Supplementary
Figure 3). Dis3l2 was found to primarily localize to the cytoplasm of V6.5 ESC, which is
consistent with other cell types6.
We carried out RNA degradation assays using affinity-purified Flag-Dis3l2. Dis3l2 was
found to preferentially degrade pre-let-7+14U over non-uridylated pre-let-7 or an unrelated
pre-miR-21 (Figure 2a). To rule out the possibility that this observed activity was due to a
co-purifying nuclease in the Flag-Dis3l2 IP we generated a mutant Dis3l2-expressing
construct by replacing a conserved residue in the catalytic domain (D389N) (Figure 1b).
Mutation of the equivalent Aspartic Acid in yeast DIS3 (D551N) abolishes exonuclease
activity without interfering with RNA binding20. Indeed Dis3l2 displayed no activity
whereas affinity-purified Dis3l2 displayed preferential activity towards pre-let--7+14U
(Figures 2b–c).
Next, to determine whether Dis3l2 is sufficient for the selective degradation of uridylated
pre-let-7 we generated recombinant Dis3l2 protein in E. coli (Figure 2d). Although the
activity of recombinant Dis3l2 (rDis3l2) was lower than that of the affinity-purified Flag-
Dis3l2 complexes we observed a similar preference for pre-let-7+14U compared with the
non-uridylated pre-let-7 using the 5 recombinant Dis3l2 protein (Figures 2e–f). To rule out
the possibility that this observed activity was due to a bacterial nuclease that might co-purify
with His-Dis3l2 we generated a mutant (D389N) rDis3l2 and confirmed that this catalytic
mutant displayed no ribonuclease activity in these assays (Supplementary Figure 4a).
Considering that uridylated pre-let-7a-1 was previously found associated with isolated Flag-
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tLin28A complexes together with our co-IP data, we next explored whether Lin28A protein
influenced Dis3l2 activity in vitro5. This analysis revealed that Lin28A had no effect on
Dis3l2 activity (Supplementary Figure 5). Next, to more quantitatively measure the substrate
preference of Dis3l2 for uridylated pre-let-7 we performed time course experiments with
rDis3l2. This revealed a strong preference for the degradation of uridylated pre-let-7
compared to non-uridylated pre-let-7, with >10-fold difference in the relative RNA stability
in these assays (Figures 2g–h). Altogether these results reveal that purified recombinant
Dis3l2 preferentially degrades uridylated pre-let-7 in vitro and the oligoU-tail serves as a
decay signal for this ribonuclease.
To further explore the functional relationship between Lin28, TUTase, and Dis3l2-mediated
RNA degradation we next performed in vitro reconstitution assays. Previously we showed
that Lin28 enhances the uridylation activity of Zcchc11 towards pre-let-7. In these assays
TUTase activity was measured by the incorporation of radiolabeled UTP3,4,16. However due
to limiting UTP concentration the oligo-U tails added in these reactions are short,
comprising only a few nucleotides. Indeed supplementing such reactions with additional
(non-radiolabeled) UTP leads to the generation of longer U-tails (Figure 3a, compare lanes
1, 2, and 3). Interestingly, addition of Dis3l2 leads to the selective degradation of the pre-
let-7 with longer U-tails (Figure 3a). These data define the minimal set of proteins and
enzymes required to recapitulate the selective degradation of pre-let-7 observed in vivo, and
raise questions regarding U-tail length requirements to stimulate Dis3l2-mediated
degradation. To address this we prepared a panel of pre-let-7 RNA substrates with varying
U-tail lengths and monitored Dis3l2 degradation activity. Tails of at least 10 uridines were
found to stimulate Dis3l2 activity with maximal stimulation observed with U-tails of 14 or
greater. This result is consistent with the average length the U-tail found on pre-let-7 RNAs
cloned and sequenced from Lin28-expressing cells5.
To examine the Dis3l2 domain requirements we generated three deletion mutants lacking
either the N-terminus, C-terminus, or both N and C-terminal regions (Figure 3d). RNA
degradation assays and electromobility shift assays (EMSA) revealed that truncation of
either the N- or the C-terminus region abrogated both Dis3l2 binding and nuclease activities
on uridylated pre-let-7 RNA (Figures 3d–e). This suggests that both the cold-shock
domain(s) as well as the S1 domain are required for binding to uridylated pre-let-7. Though
the catalytic mutant (D389N) Dis3l2 was inactive in RNA degradation assays it retained the
ability to selectively bind to uridylated pre-let-7 (Figure 3e and Supplementary Figure 4b).
RNA degradation and binding assays using an unrelated RNA, pre-miR-21−/+14U,
established the sufficiency of an oligo-U tail serving as a signal to trigger Dis3l2-mediated
decay (Supplementary Figure 4c–d).
To examine the role of Dis3l2 in the let-7 pathway we used siRNAs to deplete Lin28A,
Zcchc11, or Dis3l2 expression in mouse ESCs. We also included siRNAs that target a
related family member Dis3l1 (Figure 4a–b). We monitored effects of gene knockdown on
mature miRNA expression by q.RT-PCR and Northern blot (Figure 4c–d). While Lin28A
knockdown caused the expected accumulation of multiple let-7 miRNAs, knockdown of
Dis3l2 (or Dis3l1) had no effect. We did however observe a modest increase in let-7
expression in the Zcchc11-depleted samples as previously reported3–5. Uridylated pre-let-7
has been previously shown to be resistant to cleavage by affinity-purified Dicer complex(es)
and consistently we found pre-let-7+14U to be a poor substrate for recombinant Dicer in
processing assays. In comparison pre-let-7 was processed by Dicer to ~22 nt duplexes
(Figure 4e). Considering that pre-let-7+14U is inefficiently processed by Dicer we
postulated that knockdown of Dis3l2 in cells could lead to accumulation of uridylated pre-
let-7 without affecting levels of mature let-7. To test this we developed a sensitive q.RT-
PCR-based assay for the specific detection of uridylated pre-let-7. We used an oligo-dA
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tprimer for the reverse transcriptase first-strand cDNA synthesis step and used primers
complementary to pre-let-7 for detection of uridylated pre-let-7 by real-time PCR. This
approach allowed us to specifically detect uridylated pre-let-7 (Supplementary Figure 6a).
RNA from the knockdown samples was size fractionated to specifically measure relative
levels of uridylated pre-let-7 in the <200nt fraction and the corresponding pri-let-7
transcripts in the large >200nt fraction. This revealed the specific accumulation of uridylated
pre-let-7a-1 and pre-let-7g upon Dis3l2 knockdown (Figure 4f), whereas levels of the
corresponding pri-let-7 transcripts were unchanged (Figure 4g). PCR products were cloned
and sequenced to confirm the specificity of this assay (Supplementary Figure 6b–c). Similar
results were found using stable Dis3l2 knockdown ESCs (Supplementary Figure 7a–e). To
further confirm the role of Dis3l2 in the regulation of uridylated pre-let-7 levels we
performed Northern blot using a probe complementary to the terminal loop region of let-7g.
This revealed a slower-migrating pre-let-7 band upon Dis3l2 depletion that likely
corresponds to oligouridylated pre-let-7 (Figures 4h–i). Finally we individually depleted two
additional 3′-5′ exonucleases, Exosc10 (RRP6) and Rrp44 (Dis3) from ESCs and measured
relative pre-let-7 levels by q.RT-PCR. Knockdown of these exosome-associated nucleases
did not affect uridylated pre-let-7 levels (Supplementary Figure 8). These results provide
strong support that Dis3l2 is the downstream nuclease that mediates the decay of uridylated
pre-let-7 in the Lin28 pathway.
Our results identify Dis3l2 as a new component of the Lin28/let-7 pathway as the
downstream nuclease responsible for the decay of uridylated pre-let-7 (Supplementary
Figure 9). This contention is based on the following: First, Dis3l2 specifically associates
with uridylated pre-let-7 in RNA affinity-purifications and is detected as a component of a
Lin28A-containing ribonucleoprotein complex(es). Second, purified Dis3l2 (but not
catalytically inactive mutant Dis3l2) complexes display substrate preference for uridylated
pre-let-7 in RNA degradation assays in vitro. Third, in vitro reconstitution experiments with
recombinant Dis3l2 reveal the sufficiency of this enzyme for the preferential degradation of
uridylated pre-let-7. Last, knockdown of Dis3l2 causes the specific accumulation of
uridylated pre-let-7 in mouse ESCs.
Dis3l2 belongs to a family of related 3′-5′ exonucleases with similar domain organization to
bacterial RNase II6,21,22. Interestingly germline mutations in the Dis3l2 gene were recently
found to be responsible for Perlman syndrome, a rare, autosomal recessive, fetal overgrowth
syndrome6. In addition to being large, affected individuals are hypotonic, have
organomegally, characteristic facial dysmorphism, renal abnormalities, neurodevelopmental
problems, and a dramatically high susceptibility Wilms’ tumors (Nephroblastoma) with
>60% of surviving children developing Wilms’ tumors. Moreover Dis3l2 was found to be
mutated in ~30% of sporadic Wilms’ tumors analyzed6. It will be important to explain the
role of Dis3l2 in the genesis and development of Perlman syndrome and Wilms’ tumors.
Future experiments with knockout mouse models will shed light on question. Our work
uncovers the first physiologic RNA substrate of Dis3l2. Considering the similarities between
the disease phenotypes associated with Dis3l2 deletion and those caused by Lin28 gain-of-
function (i.e. overgrowth and tumorigenesis) it is tempting to speculate that this novel role
of Dis3l2 in the Lin28-let-7 pathway is relevant to Perlman syndrome and cancer.
Our identification of a decay pathway for uridylated RNAs raises questions about how
widespread this type of regulation might be on a transcriptome scale as well as the
mechanism by which oligouridylation promotes Dis3l2 ribonucleolytic activity. So far there
are few known examples where 3′ uridylation can serve as a decay signal; these include
histone mRNA regulation during the mammalian cell cycle, and the widespread uridylation-
dependent mRNA decapping and decay in Schizosaccharomyces pombe 23–25. This model
has analogies with other systems; for example 3′-5′ RNA decay in E. coli by the
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t‘Degradosome’ is stimulated by short poly(A) tails26,27. Similarly in Saccharomyces
cerevisiae the Trf4/Air2/Mtr4 polyadenylation (TRAMP) complex catalyzes the addition of
oligoA-tail that promotes 3′-5′ RNA decay by the exosome as part of a nuclear RNA
surveillance mechanism28,29. In the case of pre-let-7 the 3′ oligouridylation has two
consequences; 1) to block Dicer processing, and 2) to stimulate decay by Dis3l2, therefore
even though Dis3l2 displays relatively modest substrate preference for uridylated pre-let-7
in vitro, the two-step mechanism safeguards against the production of mature let-7 miRNA.
METHODS SUMMARY
Affinity pull-down assays
Synthetic pre-let-7a-1 or pre-let-7a-1+14U was conjugated to agarose beads and incubated
with whole-cell extract from P19 cells. Affinity eluate was subjected to SDS-PAGE and
Coomassie blue staining. Bands were excised and subjected to mass spectroscopic
sequencing. Protein complexes were affinity-purified using α-Flag M2 agarose beads
(Sigma).
Plasmids and cDNA cloning
Dis3l2 cDNA was cloned into pFlag-CMV2 (Sigma). Dis3l2 D389N was generated by site-
directed mutagenesis. cDNA was subcloned into pETDuet-1 for His-tagged Dis3l2
expression.
Recombinant Dis3l2 protein purification
Ni-NTA beads were used for the purification of His-Dis3l2 from IPTG induced BL21-
CodonPlus® competent bacteria (Stratagene).
RNA degradation assays
RNA degradation assays were performed using either 5′ end-labeled synthetic pre-miRNA
or uniformly labeled in vitro transcribed pre-miRNA together with Dis3l2 in RNA
degradation buffer and incubated at 37°C.
RNA Electromobility shift assays (EMSA)
EMSA experiments were performed as described previously16. Nucleoprotein complexes
were resolved by 4–20% non-denaturing TBE gel electrophoresis and visualized by
autoradiography.
Transfections and siRNA/shRNA knockdowns
All transfections were performed with Lipofectamine (Invitrogen) per manufacturer’s
instructions. Lentivirus production, infection, and stable cell selection are as described 17.
Quantitative RT-PCR
RNA was isolated using TRIzol reagent (Invitrogen) and size fractionated using mirVana™
miRNA isolation (Ambion). For detection of uridylated pre-miRNA, 1 μg (<200 nt RNA
fraction) was treated with DNase then reverse transcribed using oligo(dA)12 primer and
SuperScript III (Invitrogen). Q.RT-PCR was performed using iQ SYBR Green Supermix
(Bio-Rad).
Northern blotting
10 μg total RNA from each sample was used for Northern blotting as previously
described19.
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tDicer assays
Recombinant Flag-Dicer Protein was purified from insect cells as previously described 19.
METHODS
Cell culture
HEK293 cells were maintained in DMEM, P19 cells in MEMα+GlutaMax™-1, and ESCs in
DMEM with ESGRO (1,000 units/ml), supplemented with antibiotics, and 10% (for
HEK293, P19) or 15% (for ESC) fetal bovine serum. A Dox-inducible Flag-Lin28A ESC
line was used 3,12. The MISSION® shRNA plasmid DNA (Sigma, TRC number
TRCN0000120760 for shRNA#1 and TRCN0000120761 for shRNA#2, TRCN0000120745
for Dis3 shRNA, or TRCN0000123544 for Exosc10 shRNA) together with pLP1, pLP2, and
VSVG were transfected into 293T cells to produce lentiviral particles that were used to
infect V6.5 ESCs. The Dis3l2 shRNA stable cells were then created by puromycin (2.5 μg/
ml) selection.
Affinity pull-down assays
For RNA affinity pull-down, synthetic mmu-pre-let-7a-1 or mmu-pre-let-7a-1+14U was
conjugated to adipic acid dihydrazide agarose beads and incubated with whole-cell extract
from P19 cells 8. The affinity eluate was subjected to SDS–polyacrylamide gel
electrophoresis (SDS-PAGE) followed by Coomassie blue staining using the Colloidal Blue
Staining Kit’ (Life Technologies™). Bands were excised, and subjected to mass
spectroscopic sequencing. The sequencing results were further confirmed by Western
blotting. For affinity purification of Flag-Lin28A, KH2 ESCs were treated with Dox at 6 μg/
ml for 48 hours and then harvested in the lysis buffer (20 mM Tris-HCl, pH 8.0, 137 mM
NaCl, 1 mM EDTA, 1% (v/v) Triton X-100, 10% (v/v) Glycerol, 1.5 mM MgCl2, 1 mM
DTT, 0.2 mM PMSF) supplemented with 40 units/ml of RNase inhibitor (rRNasin,
Promega). Protein complexes were affinity-purified using α-Flag M2 agarose beads
(Sigma). Beads were extensively washed with lysis buffer for a total of seven times before
elution with 0.5 mg/ml Flag peptide. The eluates were analyzed by SDS-PAGE and Western
blotting.
Mass spectrometry
The mass spectrometric protein analysis was performed at the Proteomics Center at Boston
Children’s Hospital. Bands of interest were excised from the Coomassie-stained SDS-PAGE
gel, washed with a 2:1 ratio of 100mM ammonium bicarbonate and acetonitrile, reduced
with 10 mM DTT at 56°C for 45 minutes and alkylated for 30 minutes at room temperature,
in the dark, with 55mM Iodoacetamide. Samples were digested with sequencing grade
trypsin (Promega) at a concentration of 12.5ng/ul in 100mM ammonium bicarbonate at
37°C overnight. Peptides were extracted with 100mM ammonium bicarbonate and
acetonitrile, and then dried in a speedvac. Samples were resuspended in 5 % acetonitrile and
5 % formic acid before direct injection into the LC/MS system comprising of a nanoLC
AS-2 autosampler, a nanoLC 2D HPLC pump (both Eksigent, Dublin, CA), and an LTQ
mass spectrometer (Thermo Scientific, San Jose, CA). The LC-system for the mass
spectrometer featured an reversed phase column in-house packed into PicoTip Emitters
(New Objective, Woburn, MA) using Magic C18 (3 um, 200 Å; Michrom Bioresource)
packing material. The peptides were eluted with a 30 min linear gradient and data was
acquired in a data dependent fashion, i.e. the 6 most abundant species were selected for
fragmentation by collision induced dissociation. The .raw files were converted into .mgf
files using in-house written scripts30. For each fragment ion spectrum, only the 200 most
intense fragment ions were exported into the mgf file. The mass spectrometric data was
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tsearched against Uniprot-Mouse database using the protein identification software Protein
Pilot. The results were then filtered to include only proteins with a global FDR of 1%.
Plasmids and DNA cloning
Dis3l2 cDNA was generated by PCR using the forward (5′-
aagcttgcggccgcgAACCATCCTGACTACAAGCTGAACCTTCGG-3′) and the reverse (5′-
agacctagtcgacTCAGTCCTCAGGCTCCTCATCAGACGCC-3′) primers, and was cloned
into the NotI and SalI sites of pFlag-CMV2 (Sigma). For generating Dis3l2 D389N mutant,
site-directed mutagenesis was performed using the forward (5′-
CTGCTCGCGACCTTAATGATGCCCTCGC-3′) and the reverse (5′-
GCGAGGGCATCATTAAGGTCGCGAGCAG-3′) primers. For generating Histagged
Dis3l2, PCR product from the forward (5′-
actaggaattcgAACCATCCTGACTACAAGCTGAACCTTCGG-3′) and the reverse (5′-
aagcttgcggccgcTCAGTCCTCAGGCTCCTCATCAGACGCC-3′) primers was cloned into
the EcoRI and NotI sites of pETDuet-1. For CT-GFP and NT-GFP fusions, the GFP Fusion
TOPO TA expression kits (Invitrogen) were used. For CT-GFP fusions, the forward (5′-
ACC ATG AAC CAT CCT GAC TAC AAG CTG AAC-3′) and the reverse (5′-CGT CCT
CAG GCT CCT CAT CAG-3′) primers were used. For NT-GFP fusions, the forward (5′-
AAC CAT CCT GAC TAC AAG CTG AAC-3′) and the reverse (5′-TCA GTC CTC AGG
CTC CTC ATC AG-3′) primers were used. For deletion mutants, Dis3l2 truncated cDNA
were amplified by PCR with the forward (5′-AAC AAG CGG CCG CGA ACC ATC CTG
ACT ACA AGC TGA ACC-3′) and the reverse (5′-AAC AAG AAT TGA GTA GCC CAG
AGC AGC AGC-3′) primers to generate the C-terminus deletion mutant, with the forward
(5′-AAC AAG CGG CCG CGA GAA GAG ACC TAA GGA AAG ACT GTA TCT TCA
C-3′) and the reverse (5′-AAC AAG AAT TCA GTC CTC AGG CTC CTC ATC-3′)
primers to generate the N-terminus deletion and with the forward (5′-AAC AAG CGG CCG
CGA GAA GAG ACC TAA GGA AAG ACT GTA TCT TCA C-3′) and the reverse (5′-
AAC AAG AAT TGA GTA GCC CAG AGC AGC AGC-3′) primers to generate the N and
C-terminus deletion. These PCR products were cloned into NotI and EcoRI sites of pFLAG-
CMV2 vector (Sigma). Flag-TRBP and Flag-Trim71 constructs were as described15,19.
Recombinant Dis3l2 protein purification
Transformed BL21-CodonPlus® Competent bacteria (Stratagene) were grown to an
OD600nm of 0.4–0.6. Expression was induced 100μM IPTG for 2–3 hours. Cell pellets
were resuspended in cold lysis buffer [20mM imidazole pH 8.0 in PBS, 0.1% Phenylmethyl
sulfonyl fluoride (PMSF)] and sonicated. Cleared lysates were incubated with Ni-NTA
beads and after 90 minutes incubation at 4°C the beads were washed with 80 column
volumes wash buffer [10mM Tris (pH 7.8), 50mM imidazole pH 8.0, 500mM NaCl, 0.1%
PMSF). Bound His-tagged proteins were eluted from the column with 1 volume elution
buffer [10mM Tris (pH 7.8), 500mM imidazole pH 8.0, 500mM NaCl, 0.1% fresh PMSF]
and dialyzed overnight against BC100 [20 mM Tris-HCl (pH 7.8), 100 mM KCl, 0.2 mM
EDTA, 10% glycerol]. Purified protein was dialyzed against RNA degradation buffer (see
below) and supplemented with 20% glycerol before storage at −80°C. For affinity
purification of ectopically expressed FLAG-Lin28A or FLAG-Lin28A W46A, V6.5 ESC
were transfected using Lipofectamine 2000 (Invitrogen) and collected 48 hours later. Cells
were lysed as described above, except for the addition of RNase A (20 mg/ml final,
QIAGEN) where indicated.
RNA degradation assays
RNA degradation assays were performed in a total of 20 μl reaction using 6.25 nM 5′ end-
labeled pre-miR-21, pre-let-7a-1, or pre-let-7a-1+14U RNA (see Table 2) together with
Dis3l2 and/or Lin28A. The reactions were set up in the RNA degradation buffer (20 mM
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tHEPES-KOH pH 7.5, 50 mM KCl, 0.05 mM MgCl2, 1 mM DTT) and incubated at 37°C for
90 minutes. For time-course assays; recombinant 6x-His Dis3l2 was incubated with
radiolabeled pre-let-7a-1 or pre-let-7a-1+14U. Bands from three independent experiments
were quantified using ImageJ (NIH) and plotted using Prism (Graphpad). Values were fitted
to one-phase decay curves with error bars representing +/− s.d. (n=3). For Uridylation-
stimulated degradation assays; in vitro uridylation assays were performed as described
previously 3,4,16 except with the addition of 10μM cold competitor uridine triphosphate and
immunopurified Dis3l2 where indicated.
In vitro transcription of pre-miRNAs
In vitro transcribed pre-let-7 RNAs were generated as substrates RNA degradation assays
(in Figure 3b). DNA templates for in vitro transcription of pre-let-7 with different 3 ′ ends
by PCR amplification using were generated using a universal 5′-primer
(acggttcagcTAATACGACTCACTATAGGGTGAGGTAGTAGTTTGTACAGTTTGAGG)
(T7 promoter sequence underlined) and a 3′-primer listed in the Table 1 to amplify from a
plasmid DNA template containing pri-let-78. PCR products were cloned and sequence
verified. DNA templates (PCR products) were gel-purified and in vitro transcription was
performed according to Riboprobe in-vitro transcription systems using a-32P rGTP and T7
RNA polymerase (Promega). The labeled pre-miRNAs were treated with RQ1 DNase and
cleaned by illustra MicroSpin G-25 Column (GE Healthcare Life Sciences).
RNA Electromobility shift assays (EMSA)
EMSA experiments were performed as described previously16. Briefly, 1nM of the indicated
radiolabeled synthetic RNA was incubated in the binding buffer (50 mM Tris pH 7.6,
100mM NaCl, 10 mM β-Mercaptoethanol, 1 unit/μl RNaseOUT) with varying
concentrations of catalytically inert recombinant 6x-His Dis3L2 or recombinant 6x-His
Lin28 in the absence of competitor RNA. Nucleoprotein complexes were resolved by 4–
20% non-denaturing TBE gel electrophoresis (Biorad, #345-0059) and visualized by
autoradiography.
Antibodies and synthetic RNA
Transfections and siRNA/shRNA knockdowns
All transfections were performed with Lipofectamine (Invitrogen) per manufacturer’s
instructions. The sequences of the shRNA hairpins and siRNAs are listed in Table 3.
Lentivirus production, infection, and stable cell selection are as described 17.
mRNA and miRNA quantitative RT-PCR
Total RNA was isolated using TRIzol reagent (Invitrogen). For fractionation of less than
200 nucleotides (nt) long RNA, total RNA was processed by mirVana™ miRNA Isolation
Kit according to the manufacturer’s instructions (Cat# AM1560, Ambion). For mRNA, 100
ng of total RNA was reverse transcribed using random hexamers and SuperScript III
(Invitrogen). For mature miRNA, 10 ng of total RNA was reverse transcribed using gene-
specific stem-loop RT primers and Multiscribe reverse transcriptase (Applied Biosystems).
For pre-miRNA, 1 μg of less than 200 nt fractionated RNA was first treated with 0.66 unit
of RNase-free DNase (Promega) (60 min at 37°C), stopped with 1 mM of EDTA (10 min at
65°C), and reverse transcribed by oligo(dA)12 (60 min at 50°C) using SuperScript III
(Invitrogen). The resulting cDNA was further digested with RNase H (30 min at 37°C). For
mRNA and pre-miRNA, iQ SYBR Green Supermix (Bio-Rad) was used for quantitating the
cDNA. For mature-miRNA, TaqMan Universal PCR Master Mix, No AmpErase UNG
(Applied Biosystems) was used for cDNA detection. All quantitative PCR were performed
using iCycler iQ Multicolor Real-Time PCR Detection System (Bio-Rad). Normalization
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snoRNA142 for mature miRNAs. For all RT-PCRs, minus reverse transcriptase (-RT) and
water control samples were included and in all cases the signals were undetectable (data not
shown). The primer sequences used in this study are listed in Table 4.
Northern blotting
10 μg total RNA from each sample was used for Northern blotting as previously
described19. Probe sequences for detecting precursor and mature miRNA are as follows: 5′-
TATCTCCTGTACCGGGTGGTATCATAGACCCTCA-3′ for pre-let-7g; 5′-
AACTATACAACCTACTACCTCA-3′ for let-7a; 5′-
AACTGTACAAACTACTACCTCA-3′ for let-7g.
Dicer assays
Recombinant Flag-Dicer Protein was purified from insect cells as previously described 19.
Dicer processing of pre-let-7 or pre-let-7+14U was performed by incubating recombinant
Dicer with gel-purified 5′-end labeled synthetic pre-miRNA in a buffer containing 3.2 mM
MgCl2, 20 mMTris-HCl (pH 7.9), 0.1M KCl, 10% glycerol, 5 mM DTT, 0.2 mM PMSF, 40
units/ml of RNase inhibitor (RNasin, Promega) for 1 h at 37°C. Samples were resolved by
15% denaturing polyacrylamide gel.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We thank Robert LaPierre for technical assistance and Dr. Fei-Long Meng for Rrp44 and Exosc10 shRNA. Thanks
to Children’s Hospital Boston/IDDRC Proteomics Core for mass spectromety. R.I.G was supported by grants from
the US National Institute of General Medical Sciences (NIGMS) (R01GM086386) and The American Cancer
Society (121635-RSG-11-175-01-RMC). J.E.T. was supported by a pre-doctoral fellowship from the National
Science Foundation. R.T. was supported by a fellowship from Boston Children’s Hospital.
References
1. Thornton JE, Gregory RI. How does Lin28 let-7 control development and disease? Trends Cell Biol.
2012; 22:474–482. S0962-8924(12)00104-3 [pii]. 10.1016/j.tcb.2012.06.001 [PubMed: 22784697]
2. Heo I, et al. TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA
uridylation. Cell. 2009; 138:696–708. S0092-8674(09)00964-7 [pii]. 10.1016/j.cell.2009.08.002
[PubMed: 19703396]
3. Hagan JP, Piskounova E, Gregory RI. Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation
in mouse embryonic stem cells. Nat Struct Mol Biol. 2009; 16:1021–1025. nsmb.1676 [pii].
10.1038/nsmb.1676 [PubMed: 19713958]
4. Thornton JE, Chang HM, Piskounova E, Gregory RI. Lin28-mediated control of let-7 microRNA
expression by alternative TUTases Zcchc11 (TUT4) and Zcchc6 (TUT7). RNA. 2012; 18:1875–
1885. rna.034538.112 [pii]. 10.1261/rna.034538.112 [PubMed: 22898984]
5. Heo I, et al. Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol Cell. 2008;
32:276–284. S1097-2765(08)00660-6 [pii]. 10.1016/j.molcel.2008.09.014 [PubMed: 18951094]
6. Astuti D, et al. Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and
Wilms tumor susceptibility. Nat Genet. 2012; 44:277–284. ng.1071 [pii]. 10.1038/ng.1071
[PubMed: 22306653]
7. Roush S, Slack FJ. The let-7 family of microRNAs. Trends Cell Biol. 2008; 18:505–516. [PubMed:
18774294]
8. Viswanathan SR, Daley GQ, Gregory RI. Selective blockade of microRNA processing by Lin28.
Science. 2008; 320:97–100. 1154040 [pii]. 10.1126/science.1154040 [PubMed: 18292307]
Chang et al. Page 9
Nature. Author manuscript; available in PMC 2013 November 09.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t9. Newman MA, Thomson JM, Hammond SM. Lin-28 interaction with the Let-7 precursor loop
mediates regulated microRNA processing. RNA. 2008; 14:1539–1549. rna.1155108 [pii]. 10.1261/
rna.1155108 [PubMed: 18566191]
10. Rybak A, et al. A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during
neural stem-cell commitment. Nat Cell Biol. 2008; 10:987–993. ncb1759 [pii]. 10.1038/ncb1759
[PubMed: 18604195]
11. Ambros V, Horvitz HR. Heterochronic mutants of the nematode Caenorhabditis elegans. Science.
1984; 226:409–416. [PubMed: 6494891]
12. Zhu H, et al. Lin28a transgenic mice manifest size and puberty phenotypes identified in human
genetic association studies. Nat Genet. 2010; 42:626–630. ng.593 [pii]. 10.1038/ng.593 [PubMed:
20512147]
13. Zhu H, et al. The Lin28/let-7 axis regulates glucose metabolism. Cell. 2011; 147:81–94.
S0092-8674(11)01003-8 [pii]. 10.1016/j.cell.2011.08.033 [PubMed: 21962509]
14. Yu J, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;
318:1917–1920. 1151526 [pii]. 10.1126/science.1151526 [PubMed: 18029452]
15. Chang HM, et al. Trim71 cooperates with microRNAs to repress Cdkn1a expression and promote
embryonic stem cell proliferation. Nat Commun. 2012; 3:923. ncomms1909 [pii]. 10.1038/
ncomms1909 [PubMed: 22735451]
16. Piskounova E, et al. Lin28A and Lin28B Inhibit let-7 MicroRNA Biogenesis by Distinct
Mechanisms. Cell. 2011; 147:1066–1079. S0092-8674(11)01289-X [pii]. 10.1016/j.cell.
2011.10.039 [PubMed: 22118463]
17. Viswanathan SR, et al. Lin28 promotes transformation and is associated with advanced human
malignancies. Nat Genet. 2009; 41:843–848. [PubMed: 19483683]
18. Nam Y, Chen C, Gregory RI, Chou JJ, Sliz P. Molecular Basis for Interaction of let-7 MicroRNAs
with Lin28. Cell. 2011; 147:1080–1091. S0092-8674(11)01266-9 [pii]. 10.1016/j.cell.2011.10.020
[PubMed: 22078496]
19. Chendrimada TP, et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and
gene silencing. Nature. 2005; 436:740–744. nature03868 [pii]. 10.1038/nature03868 [PubMed:
15973356]
20. Dziembowski A, Lorentzen E, Conti E, Seraphin B. A single subunit, Dis3, is essentially
responsible for yeast exosome core activity. Nat Struct Mol Biol. 2007; 14:15–22. nsmb1184 [pii].
10.1038/nsmb1184 [PubMed: 17173052]
21. Tomecki R, et al. The human core exosome interacts with differentially localized processive
RNases: hDIS3 and hDIS3L. EMBO J. 2010; 29:2342–2357. emboj2010121 [pii]. 10.1038/emboj.
2010.121 [PubMed: 20531386]
22. Staals RH, et al. Dis3-like 1: a novel exoribonuclease associated with the human exosome. EMBO
J. 2010; 29:2358–2367. emboj2010122 [pii]. 10.1038/emboj.2010.122 [PubMed: 20531389]
23. Mullen TE, Marzluff WF. Degradation of histone mRNA requires oligouridylation followed by
decapping and simultaneous degradation of the mRNA both 5′ to 3′ and 3′ to 5′. Genes Dev.
2008; 22:50–65. 22/1/50 [pii]. 10.1101/gad.1622708 [PubMed: 18172165]
24. Norbury CJ. 3′ Uridylation and the regulation of RNA function in the cytoplasm. Biochem Soc
Trans. 2010; 38:1150–1153. BST0381150 [pii]. 10.1042/BST0381150 [PubMed: 20659020]
25. Rissland OS, Norbury CJ. Decapping is preceded by 3′ uridylation in a novel pathway of bulk
mRNA turnover. Nat Struct Mol Biol. 2009; 16:616–623. nsmb.1601 [pii]. 10.1038/nsmb.1601
[PubMed: 19430462]
26. Carpousis AJ, Vanzo NF, Raynal LC. mRNA degradation. A tale of poly(A) and multiprotein
machines. Trends Genet. 1999; 15:24–28. S0168-9525(98)01627-8 [pii]. [PubMed: 10087930]
27. Blum E, Carpousis AJ, Higgins CF. Polyadenylation promotes degradation of 3′-structured RNA
by the Escherichia coli mRNA degradosome in vitro. J Biol Chem. 1999; 274:4009–4016.
[PubMed: 9933592]
28. LaCava J, et al. RNA degradation by the exosome is promoted by a nuclear polyadenylation
complex. Cell. 2005; 121:713–724. S0092-8674(05)00442-3 [pii]. 10.1016/j.cell.2005.04.029
[PubMed: 15935758]
Chang et al. Page 10
Nature. Author manuscript; available in PMC 2013 November 09.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t29. Wyers F, et al. Cryptic pol II transcripts are degraded by a nuclear quality control pathway
involving a new poly(A) polymerase. Cell. 2005; 121:725–737. S0092-8674(05)00443-5 [pii].
10.1016/j.cell.2005.04.030 [PubMed: 15935759]
30. Renard BY, et al. When less can yield more - Computational preprocessing of MS/MS spectra for
peptide identification. Proteomics. 2009; 9:4978–4984.10.1002/pmic.200900326 [PubMed:
19743429]
Chang et al. Page 11
Nature. Author manuscript; available in PMC 2013 November 09.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tFigure 1. Dis3l2 is associated with uridylated pre-let-7
(a) Affinity-purified proteins analyzed by Coomassie blue staining and mass spectrometry.
(b) Diagrammatic representation of Dis3l2 protein, Accession number (NCBI):
NP_001165628.1. Cold-shock domains, Ribonuclease II domain (RNB), and S1 RNA-
binding domain are indicated. aa, amino acids. The mutated catalytic Aspartic Acid is
indicated. (c) Western blotting analysis of samples in (a) with indicated antibodies. (d–f) co-
IP and Western blot analyses.
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tFigure 2. Dis3l2 preferentially degrades uridylated pre-let-7
(a) Flag-Dis3l2 incubated with different radiolabeled pre-miRNAs. Where indicated, 100ng
competitor RNA was added to reduce background activity. (b) Flag-tagged Dis3l2 or mutant
Dis3l2 incubated with pre-let-7a-1+14U (c) RNA degradation assay with a titration of Flag-
Dis3l2. (d) His-Dis3l2 examined by Coomassie blue staining and Western blot. (e) Flag-
Dis3l2 and His-Dis3l2 analyzed by Western blot and activity. (f) RNA degradation assay
with a titration of His-Dis3l2. (g) Representative time course assay. (h) Quantitation of three
independent experiments as in (g) with the corresponding calculated RNA half-lives. p<0.01
[two-way analysis of variance (ANOVA) test]. Arrows indicate radiolabeled pre-miRNA
while arrowheads indicate degradation products.
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tFigure 3. Molecular determinants of Disl32 activity
(a) Reconstitution assays reveal longer Flag-uridine tails are preferred substrates for Dis3l2.
(b) RNA degradation assays with in vitro transcribed pre-let-7 RNAs with indicated 3′ U-
tail. (c) Schematic representation and Western blot of different Dis3l2 truncations used for
(d) RNA degradation assays and (e) EMSA.
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tFigure 4. Dis3l2 is required for degradation of uridylated pre-let-7 in embryonic stem cells
(a) Western blot analysis of siRNA knockdown. (b) quantitative RT-PCR (q.RT-PCR)
analysis of Dis3l1 knockdown. Error bars ±S.D. (n=3). (c) mature miRNA levels measured
by q.RT-PCR. Error bars ±S.D. (n=3) and (d) Northern blot. (e) Dicer processing assay with
Arrows indicating pre-miRNA and arrowhead indicating Dicer products. (f)(g) 1 μg of total
RNA from the samples in (a) was fractionated into >200 nt and <200 nt long RNA and
relative levels of pre-let-7 (f) or pri-let-7 (g) RNA were quantitated by real-time PCR. Error
bars ±S.D. (n=3). (h) Western blot analysis of Dis3l2 cells. (i) Northern blot analysis of pre-
let-7g.
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Table 1
pre-let-7g-(U)n 3′-primer
pre-let-7g-0U GCAAGGCAGTGGCCTGTACAGTTATC
pre-let-7g-1U aGCAAGGCAGTGGCCTGTACAGTTATC
pre-let-7g-3U aaaGCAAGGCAGTGGCCTGTACAGTTATC
pre-let-7g-5U aaaaaGCAAGGCAGTGGCCTGTACAGTTATC
pre-let-7g-10U aaaaaaaaaaGCAAGGCAGTGGCCTGTACAGTTATC
pre-let-7g-14U aaaaaaaaaaaaaaGCAAGGCAGTGGCCTGTACAGTTATC
pre-let-7g-20U aaaaaaaaaaaaaaaaaaaaGCAAGGCAGTGGCCTGTACAGTTATC
pre-miR-21 forward acggttcagcTAATACGACTCACTATAGGGTAGCTTATCAGACTGATGTTGACTG
pre-miR-21 reverse GACAGCCCATCGACTGCTGTTG
pre-miR-21-14U reverse aaaaaaaaaaaaaaGACAGCCCATCGACTGCTGT
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Table 2
Antibodies and the working concentrations
Antibody Cat. # Source Conc. used
α-Dis3l2 NBP1-84740 Novus Biologicals 0.4 μg/ml
α-Zcchc11 18980-1-AP ProteinTech Group 1:1,000
α-Zcchc6 Custom-made Open Biosystems 1:500
α-Rrp44 Cat #14689-1-AP ProteinTech Group 1:1000
α-Exosc10 Cat # ab50558 Abcam 1 μg/ml
α-Lin28A (A177) #3978 Cell Signaling 1:1,000
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Table 3
The synthetic RNA sequences
RNA Cat. # Source Sequence
mmu-pre-let-7a-1 N/A Dharmacon UGAGGUAGUAGGUUGUAUAGUUUUAGGGUCACACCCACCACUGGGAGAUAACUAUACAAUCUACUGUCUUUCC
mmu-pre-let-7a-1+14U N/A Dharmacon UGAGGUAGUAGGUUGUAUAGUUUUAGGGUCACACCCACCACUGGGAGAUAACUAUACAAUCUACUGUCUUUCCUUUUUUUUUUUUUU
mmu-pre-miR-21 N/A Dharmacon UAGCUUAUCAGACUGAUGUUGACUGUUGAAUCUCAUGGCAACAGCAGUCGAUGGGCUGUC
control siRNA #1 D-001810-01 Dharmacon UGGUUUACAUGUCGACUAA
control siRNA #2 D-001810-02 Dharmacon UGGUUUACAUGUUGUGUGA
Lin28A siRNA Custom Dharmacon GGGUUGUGAUGACAGGCAA
Zcchc11 siRNA J-065226-06 Dharmacon GGGCUAAGCUGUGCUAUAU
mouse Dis3l2 siRNA#1 J-054755-10 Dharmacon CCGCUUUGCUGACGUCAUA
mouse Dis3l2 siRNA#2 J-054755-11 Dharmacon GAAUUUACGUACCUCUCAA
mouse Dis3l1 siRNA#1 J-054584-10 Dharmacon AGGAACUACUGGACGGAAA
mouse Dis3l1 siRNA#2 J-054584-11 Dharmacon UGAAACAGAAGGCGUAUUU
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Table 4
Primer sequences used in quantitative PCR
Target gene Forward sequence Reverse sequence
pre-let-7a-1 TGAGGTAGTAGGTTGTATAGTTTTAGGG GGAAAGACAGTAGATTGTATAGTTATC
pri-let-7a-1 CTTTCAACATTCACCCTGGATGTTC GAGACCCCATGAATGCAGACTTT
pre-let-7g TGAGGTAGTAGTTTGTACAGTTTGAGG GCAAGGCAGTGGCCTGTACAGTTATC
pri-let-7g GTTCTCTTTTGCCTGATTCCAGG CATTTGGTAGCTGGTGCACTG
U6 CTCGCTTCGGCAGCACA AACGCTTCACGAATTTGCGT
ACTB CAGAAGGAGATTACTGCTCTGGCT TACTCCTGCTTGCTGATCCACATC
Dis3l1 AGTTGACAGACATAGCTCGCCACA TGGTTGGCTAGGATCATGCACTCA
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